The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cataloging genomic and transcriptomic features of relapsed SCLC.
 
Sid Devarakonda
Consulting or Advisory Role - Acrotech Biopharma; Apollomics; AstraZeneca; Boehringer Ingelheim; Boehringer Ingelheim; Caris Life Sciences; Daiichi Sankyo/Astra Zeneca; Johnson & Johnson/Janssen; Lilly; Nuvation Bio; Oncohost; Takeda
Speakers' Bureau - AstraZeneca; Johnson & Johnson/Janssen
 
Sumithra Sankararaman
No Relationships to Disclose
 
My Hoang
No Relationships to Disclose
 
Zach Skidmore
No Relationships to Disclose
 
Brett Herzog
No Relationships to Disclose
 
Kymberlie Pepin
No Relationships to Disclose
 
Joshua McMichael
No Relationships to Disclose
 
Jeffrey Ward
Employment - Pfizer (I)
Consulting or Advisory Role - AstraZeneca; Guidepoint Inc; Jazz Pharmaceuticals; Novocure; Obsidian Therapeutics
Research Funding - A2 Biotherapeutics (Inst); Asher Biotherapeutics (Inst); AstraZeneca (Inst); BioNTech SE (Inst); Genmab (Inst); Harpoon therapeutics (Inst); Instil Bio (Inst); Novocure (Inst); Pfizer (Inst); Roche/Genentech (Inst); WindMIL (Inst)
Travel, Accommodations, Expenses - Novocure
 
Daniel Morgensztern
Stock and Other Ownership Interests - Abbott Laboratories; Bristol-Myers Squibb/Medarex
Consulting or Advisory Role - Abbvie; Arcus Biosciences; Bayer; Bristol-Myers Squibb/Medarex; G1 Therapeutics; Johnson & Johnson/Janssen; Lilly Medical; Mirati Therapeutics; Natera; Tubulis GmbH
Research Funding - Abbvie (Inst); Altum Pharmaceuticals (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Baxter (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EpicentRx (Inst); Genprex (Inst); Heat Biologics (Inst); Hybercell (Inst); ImmunityBio (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); NeoImmuneTech (Inst); Pfizer (Inst); Roche (Inst); Surface Oncology (Inst); Y-mAbs Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Genprex
 
Saiama Waqar
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Gilead Sciences; Johnson & Johnson/Janssen; Pfizer
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Elevation Oncology (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Nuvalent, Inc. (Inst); Ribon Therapeutics (Inst); Roche (Inst); Xcovery (Inst)
 
Malachi Griffith
No Relationships to Disclose
 
Obi Griffith
Consulting or Advisory Role - Jaime Leandro Foundation
 
Trudy Oliver
Honoraria - Illumina; OncLive Clinical Congress Consultants; Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Ramaswamy Govindan
No Relationships to Disclose